TrialDrugs in R&D2025

Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study.

Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.